Lars Petersen, Fujifilm Diosynth Biotechnologies president and CEO

Q&A: Fu­ji­film Diosynth’s new CEO Lars Pe­tersen talks pri­or­i­ties and plans for the CD­MO

Last week saw a change at the top for the con­tract man­u­fac­tur­er Fu­ji­film Diosynth Biotech­nolo­gies, with Lars Pe­tersen re­plac­ing Mar­tin Mee­son as pres­i­dent and CEO.

Pe­tersen has been in the man­u­fac­tur­ing busi­ness for well over 20 years, work­ing at ma­jor man­u­fac­tur­ers such as No­vo Nordisk, Genen­tech and Bio­gen. At Fu­ji­film, where Pe­tersen has been for the last four years, he most re­cent­ly served as COO of a man­u­fac­tur­ing site in Hillerød, Den­mark, and head­ed up the large-scale strate­gic busi­ness unit.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.